Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07174648 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.

Study acronym: RAPID-IT
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: May 1, 2026 to Dec 1, 2026
    • Site details revised
    • Collaborators: details revised at 1 of 4 entries
    • Eligibility criteria expanded, about 5 words
  2. Start date: Jan 2, 2026 to May 1, 2026
    • Secondary endpoints expanded, about 101 words
    • Collaborators: 5 to 4
    v3
  3. Study description expanded, about 1 wordv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is being done to learn more about the disease in Ituri and to evaluate a new rapid test that may help doctors find the disease more quickly. This research includes characterisation of clinical presentations and pathology of plague, as well as identification of circumstances that may increase the risk of infection. Biological samples collected include blood, mouth swab, saliva, a bubo aspirate and a sputum sample (the latter only in case of plague in the lungs). These samples will be used to test the performance of the new rapid study test.
Trial Details
NCT Number NCT07174648
Lead Sponsor Institute of Tropical Medicine, Belgium
Collaborators: Institut Pasteur, Université Paris-Saclay, Centre de Recherche en Maladies Tropicales de L'Ituri (CRMT), Institut National pour la Recherche Biomedicale (INRB)
Conditions
(from sponsor)		 Plague, Bubonic; Plague, Skin, Plague, Pneumonic
Related terms Plague
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov